<DOC>
	<DOC>NCT02086019</DOC>
	<brief_summary>For octogenarian patients with NSTEMI (non-ST segment elevation myocardial infarction) an invasive-guided strategy will prove superior to a conservative strategy with respect to a combined endpoint of all cause mortality and non-fatal myocardial infarction.</brief_summary>
	<brief_title>Revascularisation or Medical Therapy in Elderly Patients With Acute Anginal Syndromes</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Heparin, Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<criteria>AGE&gt;80 NonSTEMI characteristic chest pain accompanied by Typical ischaemic ECG changes A troponin rise Suitable for conservative or invasive strategy Lack of suitability for whatever clinical reason to be randomised eg dementia, comorbidity Acute STEMI Cardiogenic shock Platelet count =50 x 109/mm3 Patient life expectancy &lt; 1 year Known allergies to clopidogrel, aspirin, heparin, stainless steel, IV contrast or stent drug elutant Recent major GI haemorrhage (within 3 months) Any previous cerebral bleeding episode Participation in another investigational drug or device study Patient unable to give consent Clinical decision precluding the use of stents</criteria>
	<gender>All</gender>
	<minimum_age>80 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Revascularisation, octogenarian,acute coronary syndromes</keyword>
</DOC>